... of a potential medicine for alpha-1 antitrypsin deficiency and the first clinical trial for CTX-001, which it is co-developing with Crispr Therapeutics Inc., ...
Source link
... of a potential medicine for alpha-1 antitrypsin deficiency and the first clinical trial for CTX-001, which it is co-developing with Crispr Therapeutics Inc., ...
Source link